The impact of a medically directed student registered nurse anesthesia staffing model on Postprocedural patient outcomes
In 2018, the American Society of Anesthesiologists stated that student registered nurse anesthetists (SRNAs) “are not yet fully qualified anesthesia personnel.” It remains unclear, however, whether postprocedural outcomes are affected by SRNAs providing anesthesia care under the medical direction of...
Gespeichert in:
Veröffentlicht in: | Journal of clinical anesthesia 2024-06, Vol.94, p.111413, Article 111413 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | In 2018, the American Society of Anesthesiologists stated that student registered nurse anesthetists (SRNAs) “are not yet fully qualified anesthesia personnel.” It remains unclear, however, whether postprocedural outcomes are affected by SRNAs providing anesthesia care under the medical direction of anesthesiologists, as compared with medically directed anesthesiology fellows or residents, or certified registered nurse anesthetists (CRNAs). We therefore aimed to examine whether medically directed SRNAs serving as in-room anesthesia providers impact surgical outcomes.
Retrospective, matched-cohort analysis.
Adult patients (≥18 years old) undergoing inpatient surgery between 2000 and 2017 at a tertiary academic medical center.
15,365 patients exclusively cared for by medically directed SRNAs were matched to 15,365 cared for by medically directed CRNAs, anesthesiology residents, and/or fellows.
None.
The primary composite outcome was postoperative occurrence of in-hospital mortality and six categories of major morbidities (infectious, bleeding, serious cardiac, gastrointestinal, respiratory, and urinary complications). In-hospital mortality was analyzed as the secondary outcome.
In all, 30,730 cases were matched using propensity score matching to control for potential confounding. The primary outcome was identified in 2295 (7.5%) cases (7.5% with exclusive medically directed SRNAs vs 7.4% with medically directed CRNAs, residents and/or fellows; relative risk, 1.02; 95% CI, 0.94–1.11). Thus, our effort to determine noninferiority (10% difference in relative risk) with other providers was inconclusive (P = .07). However, the medically directed SRNA group (0.8% [118]) was found to be noninferior (P |
---|---|
ISSN: | 0952-8180 1873-4529 1873-4529 |
DOI: | 10.1016/j.jclinane.2024.111413 |